Header Logo

Connection

MARTA ALONSO to Cell Line, Tumor

Back to Details
This is a "connection" page, showing publications MARTA ALONSO has written about Cell Line, Tumor.
MARTA ALONSO
Connection Strength
0.430
Cell Line, Tumor
  1. Critical Role of Autophagy in the Processing of Adenovirus Capsid-Incorporated Cancer-Specific Antigens. PLoS One. 2016; 11(4):e0153814.
    View in: PubMed
    Score: 0.047
  2. Targeting brain tumor stem cells with oncolytic adenoviruses. Methods Mol Biol. 2012; 797:111-25.
    View in: PubMed
    Score: 0.035
  3. Delta-24-RGD in combination with RAD001 induces enhanced anti-glioma effect via autophagic cell death. Mol Ther. 2008 Mar; 16(3):487-93.
    View in: PubMed
    Score: 0.027
  4. Adenovirus-based strategies overcome temozolomide resistance by silencing the O6-methylguanine-DNA methyltransferase promoter. Cancer Res. 2007 Dec 15; 67(24):11499-504.
    View in: PubMed
    Score: 0.027
  5. Systemic toxicity-efficacy profile of ICOVIR-5, a potent and selective oncolytic adenovirus based on the pRB pathway. Mol Ther. 2007 Sep; 15(9):1607-15.
    View in: PubMed
    Score: 0.026
  6. Expression of transcription factor E2F1 and telomerase in glioblastomas: mechanistic linkage and prognostic significance. J Natl Cancer Inst. 2005 Nov 02; 97(21):1589-600.
    View in: PubMed
    Score: 0.023
  7. Local Treatment of a Pediatric Osteosarcoma Model with a 4-1BBL Armed Oncolytic Adenovirus Results in an Antitumor Effect and Leads to Immune Memory. Mol Cancer Ther. 2022 03 01; 21(3):471-480.
    View in: PubMed
    Score: 0.018
  8. The Different Temozolomide Effects on Tumorigenesis Mechanisms of Pediatric Glioblastoma PBT24 and SF8628 Cell Tumor in CAM Model and on Cells In Vitro. Int J Mol Sci. 2022 Feb 11; 23(4).
    View in: PubMed
    Score: 0.018
  9. The oncolytic adenovirus VCN-01 promotes anti-tumor effect in primitive neuroectodermal tumor models. Sci Rep. 2019 10 07; 9(1):14368.
    View in: PubMed
    Score: 0.015
  10. Localized Treatment with Oncolytic Adenovirus Delta-24-RGDOX Induces Systemic Immunity against Disseminated Subcutaneous and Intracranial Melanomas. Clin Cancer Res. 2019 11 15; 25(22):6801-6814.
    View in: PubMed
    Score: 0.015
  11. The oncolytic virus Delta-24-RGD elicits an antitumor effect in pediatric glioma and DIPG mouse models. Nat Commun. 2019 05 28; 10(1):2235.
    View in: PubMed
    Score: 0.015
  12. Delta-24-RGD combined with radiotherapy exerts a potent antitumor effect in diffuse intrinsic pontine glioma and pediatric high grade glioma models. Acta Neuropathol Commun. 2019 04 29; 7(1):64.
    View in: PubMed
    Score: 0.015
  13. Assessment of metabolic patterns and new antitumoral treatment in osteosarcoma xenograft models by [18F]FDG and sodium [18F]fluoride PET. BMC Cancer. 2018 Nov 29; 18(1):1193.
    View in: PubMed
    Score: 0.014
  14. GPR56/ADGRG1 Inhibits Mesenchymal Differentiation and Radioresistance in Glioblastoma. Cell Rep. 2017 Nov 21; 21(8):2183-2197.
    View in: PubMed
    Score: 0.013
  15. Development of a DIPG Orthotopic Model in Mice Using an Implantable Guide-Screw System. PLoS One. 2017; 12(1):e0170501.
    View in: PubMed
    Score: 0.012
  16. Salinomycin induced ROS results in abortive autophagy and leads to regulated necrosis in glioblastoma. Oncotarget. 2016 May 24; 7(21):30626-41.
    View in: PubMed
    Score: 0.012
  17. Soluble Tie2 overrides the heightened invasion induced by anti-angiogenesis therapies in gliomas. Oncotarget. 2016 Mar 29; 7(13):16146-57.
    View in: PubMed
    Score: 0.012
  18. Endoplasmic reticulum stress-inducing drugs sensitize glioma cells to temozolomide through downregulation of MGMT, MPG, and Rad51. Neuro Oncol. 2016 08; 18(8):1109-19.
    View in: PubMed
    Score: 0.012
  19. Characterization of the Antiglioma Effect of the Oncolytic Adenovirus VCN-01. PLoS One. 2016; 11(1):e0147211.
    View in: PubMed
    Score: 0.012
  20. The Oncolytic Adenovirus VCN-01 as Therapeutic Approach Against Pediatric Osteosarcoma. Clin Cancer Res. 2016 05 01; 22(9):2217-25.
    View in: PubMed
    Score: 0.012
  21. The oncolytic adenovirus ?24-RGD in combination with cisplatin exerts a potent anti-osteosarcoma activity. J Bone Miner Res. 2014 Oct; 29(10):2287-96.
    View in: PubMed
    Score: 0.011
  22. Involvement of miRNAs in the differentiation of human glioblastoma multiforme stem-like cells. PLoS One. 2013; 8(10):e77098.
    View in: PubMed
    Score: 0.010
  23. Interspecies adenovirus fiber shows "evolutionary" advantage for oncolytic therapy of gliomas. Cancer Biol Ther. 2008 May; 7(5):794-6.
    View in: PubMed
    Score: 0.007
  24. Cell cycle-dependent nuclear export of phosphatase and tensin homologue tumor suppressor is regulated by the phosphoinositide-3-kinase signaling cascade. Cancer Res. 2007 Nov 15; 67(22):11054-63.
    View in: PubMed
    Score: 0.007
  25. Examination of the therapeutic potential of Delta-24-RGD in brain tumor stem cells: role of autophagic cell death. J Natl Cancer Inst. 2007 Sep 19; 99(18):1410-4.
    View in: PubMed
    Score: 0.007
  26. Downmodulation of E1A protein expression as a novel strategy to design cancer-selective adenoviruses. Neoplasia. 2005 Aug; 7(8):723-9.
    View in: PubMed
    Score: 0.006
  27. A novel E1A-E1B mutant adenovirus induces glioma regression in vivo. Oncogene. 2004 Mar 11; 23(10):1821-8.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.